Navigation Links
Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
Date:6/16/2008

ROCKVILLE, Md., June 16 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Piper Jaffray Europe conference at 11:20 am. (GMT) on June 24, 2008 at The ANdAZ Hotel in London, UK. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing a new, efficient manufacturing solution. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
2. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
3. Novavax Reports First Quarter 2008 Financial Results
4. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax CEO to Present at the World Vaccine Congress 2008
7. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
8. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
9. Novavax CEO to Present at BIO CEO & Investor Conference
10. Celator(R) Pharmaceuticals to Present at 2008 BIO International Convention
11. Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall...lcompanyfocusedondevelopingandcommercializingnovel...iTonno,PresidentandChiefExecutiveOfficer,isschedul...nference,tobeheldDecember1-2,2009atTheNewYorkPalac...nGhiglieri,ChiefFinancialOfficer,willbeavailableto...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatient..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEt...y"),aglobalbiopharmaceuticalcompanyfocusedonendocr...cydatafromaPhase2studywithitstargetedcytotoxicpept...thadvancedorrecurrentendometrialcancer.Inapersonal...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstC...cedthatRandyScott,GenomicHealth,sExecutiveChairman...onferenceinNewYorkCityonTuesday,December1,2009at10...hivedwebcastofthepresentation,visittheInvestorRela...stor.genomichealth.com .Pleaseconnecttothewebsitea...
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellT...willpresentatthe21stAnnualPiperJaffrayHealthCareCo...ttheNewYorkPalaceHotel. ,, CTIwillpresentonTues...oor).AliveaudiowebcastofCTI,spresentationwillbeava...availableforreplayafterwards. , ,PiperJaffrayHeal...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...omic (OTC,Bulletin Board: TBIO) today announced th..., will present at the Rodman & Renshaw 10th Annual...2008 at the New York,Palace Hotel in New York City...Officer, will be available to respond to questions...enshaw 10th Annual Healthcare Conference Date: ...
...ThromboGenics NV,(Euronext Brussels: THR), a biote...for eye disease, vascular disease and cancer, is t... period ended 30 September 2008., Patrik De Haes,...ncement, said: "ThromboGenics, clinical developmen... are now working hard to prepare for the,Phase III...
... Genomics to Present at Rodman & Renshaw,10th Annu...30 GMT, by,Rosetta Genomics Ltd nasdaq:ROSG over P...the company that new webcast information has been ...ed release follows:, , Rosetta Genomics Ltd. (Na...RNA-based diagnostics, announced today it,will pre...
Other Biology Technology:Transgenomic to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2ThromboGenics N.V.: Business Update 2ThromboGenics N.V.: Business Update 3ThromboGenics N.V.: Business Update 4ThromboGenics N.V.: Business Update 5ThromboGenics N.V.: Business Update 6ThromboGenics N.V.: Business Update 7ThromboGenics N.V.: Business Update 8/C O R R E C T I O N -- Rosetta Genomics Ltd/ 2/C O R R E C T I O N -- Rosetta Genomics Ltd/ 3/C O R R E C T I O N -- Rosetta Genomics Ltd/ 4/C O R R E C T I O N -- Rosetta Genomics Ltd/ 5/C O R R E C T I O N -- Rosetta Genomics Ltd/ 6
(Date:11/25/2009)...y be just as vital to your health as what you eat,...gical Studies. Their experiments in mice revealed ...enes in the liverthe body,s metabolic clearinghous...e body,s circadian clock as conventional wisdom ha...y of a large number of genes completely independen...
(Date:11/24/2009)... flabby arteries from collapsing have been true li...no longer needed -- once the arteries are strength... had no choice but to leave them in place. , Pro...tment of Biomedical Engineering has developed a ne... where they,re needed, then dissolves. , "Our ne...
(Date:11/24/2009)...s a matter of debate. A high-profile study a few y... of their carbon from trees and leaves, evidence f...quatic ecosystems. , But new research from the U...o be true. Algae provide a much richer diet for fi...ublished this week in the Proceedings of the Nati...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Researchers focus on helping dying patients take care of unfinished business 61554 1Researchers focus on helping dying patients take care of unfinished business 61554 2Researchers focus on helping dying patients take care of unfinished business 61554 3Members of Congress university leaders scientists launch ScienceWorksForUS 10775 1Members of Congress university leaders scientists launch ScienceWorksForUS 10775 2Members of Congress university leaders scientists launch ScienceWorksForUS 10775 3Members of Congress university leaders scientists launch ScienceWorksForUS 10775 4Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 61551 1Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 61551 2Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 61551 3Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 61551 4
... This release is available in French and Span...om more than 160 endorsed science projects assembl...nched in March 2007, the IPY covers a two-year per... the alternate seasons in both polar regions. A jo...ts to better monitor and understand the Arctic and...
... 47% Growth in Fourth Quarter Revenues , , WALL, ...lletin Board: BKYI), a leader in wireless public s...lutions, today reported results for the fourth qua...y,s results reflected profitability for the fourth...well as strong revenue growth for the quarter and ...
... Stem cells scientists at UCLA showed for the fir...cells can be differentiated into electrically acti...ying and treating neurological disorders. , Addi...ells appeared to be similar in function and effici...lls, although further testing needs to be done to ...
Other Biology News:Polar research reveals new evidence of global environmental change 2Polar research reveals new evidence of global environmental change 3BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 2BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 3BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 4BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 5BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 6UCLA stem cells scientists make electrically active motor neurons from iPS cells 2
Electroporation Cuvettes, 4 mm gap. 50 from Thermo Scientific
...rm of Tobacco Etch Virus (TEV) protease that is hi...ly more stable than native TEV protease, resulting...y recognizes a seven amino acid (Glu-Asn-Leu-Tyr-P...it useful for removing affinity tags from fusion p...
...ble quadrupole MS detector optimized for HPLC uses... and 2-D LC, as well as capillary and prep scale s... create a finer spray mist for high sensitivity, e...ile providing for high reliability, lower source c...
Rabbit Anti-S-100A10 (H-80) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: